Double-Blind Study of Timunox (Thymopentin) in Asymptomatic HIV-Infected Patients Receiving Either Mono (AZT or ddI) or Combination (AZT / ddI or AZT / ddC) Anti-Retroviral Therapy
- Conditions
- HIV Infections
- Registration Number
- NCT00002109
- Lead Sponsor
- Immunobiology Research Institute
- Brief Summary
To confirm results from a previous study in which the combination of thymopentin plus zidovudine ( AZT ), an antiretroviral agent, slowed disease progression in HIV-infected asymptomatic patients. To evaluate the efficacy and safety of thymopentin in HIV-infected asymptomatic patients receiving either monotherapy with AZT, didanosine ( ddI ), or stavudine ( d4T ), or combination antiretroviral therapy with AZT / ddI or AZT / zalcitabine ( ddC ).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (45)
Cleveland Clinic
🇺🇸Cleveland, Ohio, United States
Fisher Med Group
🇺🇸Phoenix, Arizona, United States
Ctr for Special Immunology
🇺🇸New York, New York, United States
Beer Med Group
🇺🇸Los Angeles, California, United States
Conant Med Group
🇺🇸San Francisco, California, United States
Gottlieb Med Group
🇺🇸Pasadena, California, United States
AIDS Community Research Consortium
🇺🇸Redwood City, California, United States
Harbor - UCLA Med Ctr
🇺🇸Torrance, California, United States
HIV Research Group
🇺🇸San Diego, California, United States
Dr Larry Bruni
🇺🇸Washington, District of Columbia, United States
Pacific Oaks Med Group
🇺🇸Sherman Oaks, California, United States
Saint Joseph's Hosp / Infectious Disease Rsch Institute
🇺🇸Tampa, Florida, United States
West Paces Clinical Research Inc
🇺🇸Atlanta, Georgia, United States
Northwestern Univ Med Ctr
🇺🇸Chicago, Illinois, United States
Kansas City AIDS Research Consortium
🇺🇸Kansas City, Missouri, United States
Rush Presbyterian - Saint Luke's Med Ctr
🇺🇸Chicago, Illinois, United States
Infectious Diseases Research Clinic / Indiana Univ Hosp
🇺🇸Indianapolis, Indiana, United States
Univ of Kansas School of Medicine
🇺🇸Wichita, Kansas, United States
Van Etten Hosp / Bronx Municipal Hosp Ctr
🇺🇸Bronx, New York, United States
Dr David DiPietro
🇺🇸New York, New York, United States
CRI of New England
🇺🇸Brookline, Massachusetts, United States
Dr Howard A Grossman
🇺🇸New York, New York, United States
Dr Patrick Hennessey
🇺🇸New York, New York, United States
Associates Med and Mental Health
🇺🇸Tulsa, Oklahoma, United States
Dr Joel Godbey
🇺🇸Portland, Oregon, United States
Philadelphia FIGHT
🇺🇸Philadelphia, Pennsylvania, United States
Graduate Hosp
🇺🇸Philadelphia, Pennsylvania, United States
Central Texas Med Foundation
🇺🇸Austin, Texas, United States
Univ of Puerto Rico Med Sciences Campus
🇵🇷Rio Piedras, Puerto Rico
Nelson-Tebedo Community Clinic
🇺🇸Dallas, Texas, United States
Initiativa Comunitaria de Investigacion
🇵🇷San Juan, Puerto Rico
Houston Clinical Research Network
🇺🇸Houston, Texas, United States
New York Hosp - Cornell Med Ctr
🇺🇸New York, New York, United States
SUNY / Health Sciences Ctr at Stony Brook
🇺🇸Stony Brook, New York, United States
Dr Gary Blick
🇺🇸Greenwich, Connecticut, United States
Kaiser Permanente Med Ctr
🇺🇸San Francisco, California, United States
Community Research Initiative
🇺🇸Coral Gables, Florida, United States
Lovelace Scientific Resource
🇺🇸Albuquerque, New Mexico, United States
Systemic Mycoses Pathogen Study Group / Wash Univ Sch of Med
🇺🇸St. Louis, Missouri, United States
Dr Christopher McNulty
🇺🇸Dallas, Texas, United States
Novum Inc
🇺🇸Kirkland, Washington, United States
Stratogen of South Florida
🇺🇸Miami Beach, Florida, United States
Infectious Disease Research Institute Inc
🇺🇸Tampa, Florida, United States
Stratogen of Ft Lauderdale
🇺🇸Fort Lauderdale, Florida, United States
Hampton Roads Med Specialists
🇺🇸Hampton, Virginia, United States